Uncategorized

FEMCAT study evaluating value of femtosecond cataract surgery

by  • 

Almost 1,800 subjects have been enrolled in the French FEMCAT study evaluating the clinical value and cost-effectiveness of femtosecond laser-assisted cataract surgery, a speaker said at the European Society of Cataract and Refractive Surgeons meeting in Barcelona.The study will be completed in the first half of 2016. It is designed to provide a scientific basis for the potential adoption of femtosecond laser-assisted cataract surgery in the French health care system, Béatrice Cochener, MD, PhD, said.

Read more →

Business, News

Glaukos Establishes Direct Sales Organization and Launches iStent inject® Trabecular Micro-Bypass Stent in Australia

by  • 

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it has established a direct sales organization and launched the iStent inject® Trabecular Micro-Bypass Stent in Australia. The iStent inject is approved by the Australian Therapeutics Goods Administration for use in conjunctio


Read more →

Uncategorized

Ladas Super Surface dinâmica ajuda a otimizar e refinar os cálculos da LIO

by  • 

Historicamente, somos aconselhados a otimizar a fórmula de LIO específica de nossos pacientes para prever melhor a refração pós-cirúrgica e fornecer melhores resultados visuais. Isto significa que precisamos analisar os dados do paciente e, então, realizar os ajustes para que os futuros cálculos da LIO sejam exatos.A ideia é que existem diferenças na calibração dos dispositivos utilizados em biometria, e inclusive diferenças nas técnicas cirúrgicas, que podem influenciar o cálculo da potência da LIO e, assim, o resultado refrativo pós-cirúrgico. Isto faz sentido porque um cerátomo lê 0,5 D diferente (Read more...)